Pharm-Olam Spain

Pharm-Olam has conducted clinical trials in Spain since 2004 and we have an office in the capital city of Madrid. Our studies in Spain have supported successful US NDA and EMA approval in gram positive infections. Our Madrid office supports regional staff in Portugal.

Pharm-Olam offers comprehensive services and functional outsourcing for Phase I to IV clinical research studies in Spain, including monitoring, regulatory, pharmacovigilance (including EudraVigilance), data management, project management, and biostatistics.

For more information on conducting clinical trials with Pharm-Olam in Spain, please Contact Us.

Office Location: Madrid

Spain Demographics

Population: 40.5 million (77% urbanized)
Median Age: 41.1 years
Language: Spanish

Regulatory Authorities

Ministry of Health and Consumption (in Spanish)

Clinical Trials in Spain

clinicaltrials.gov Active Studies
EU Clinical Trials Register Active Studies

Argentina (Buenos Aires), Belarus (Minsk), Belgium (Brussels), Brazil (São Paulo), Bulgaria (Sofia), Canada (Toronto), Croatia (Zagreb), Czech Rep. (Prague), Georgia (Tbilisi), Germany (Munich), Hungary (Budapest), India (Bangalore), Italy (Milan), Kazakhstan (Almaty), Mexico (Mexico City), Poland (Warsaw), Romania (Bucharest), Russia (Moscow, St. Petersburg, Novosibirsk), Serbia (Belgrade), Spain (Madrid), South Africa (Johannesburg), Ukraine (Kiev), United Kingdom (London), United States (Houston, Princeton, Research Triangle Park)